home / stock / sny / sny articles

SNY Articles, Sanofi - From 09/27/23

Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate | Benzinga

The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's ...
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit | Benzinga

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.4...

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Near Intelligence, Inc. (NASDAQ: NIR) g...

Gold Down Over 1%; FedEx Shares Rise On Earnings Beat | Benzinga

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 150 points on Thursday. The Dow traded down 0.46% to 34,284.15 w...
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected | Benzinga

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 150 points on Thursday. Following the market opening Thursday, the Do...

Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today? | Benzinga

Travere Therapeutics Inc (NASDAQ: TVTX) announced topline two-year confirmatory secondary endpoint results from its head-to-head Pha...

Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories | Benzinga

Benzinga Elon Musk-Backed Brain Implant Firm Neuralink Starts Participant Enrollment In Brain Implant Human Trial For Paralysis Elon Musk's&nb...
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray | Benzinga

The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (ep...

Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs | Benzinga

On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respi...

'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi | Benzinga

First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 ...
Previous 10 Next 10